Vitiligo Registry for Adults and Children in the UK
Key facts
- Who runs it
- The Royal Wolverhampton Hospitals NHS Trust
- Where
- Wolverhampton, United KingdomSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 30 people, planned
- Starts
- 15 Dec 2026
- Expected to end
- Feb 2030
- Type of study
- Observational
- Record updated
- 15 September 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Paediatric and adult patients with vitiligo under management in secondary care
- Written informed consent for study participation obtained from the patient or parents / legal guardian, with assent as appropriate by the patient, depending on the level of understanding
- Participants consent to participate in long-term follow up and access to all relevant medical records as needed by the study team
- Clinical diagnosis of vitiligo made by a dermatologist
- Willingness to comply with all study requirements
- Competent use of English language, according to patient's age (capable of understanding patient questionnaires)
Who cannot take part
- Insufficient understanding of the study by the patient and/or parent/guardian
- Patients with vitiligo/their parents or guardians, who do not provide consent for participation
Where in United Kingdom
- The Royal Wolverhampton NHS TrustWolverhampton, United KingdomContact: Viktoria EleftheriadouNo longer taking part
About the trial
What the trial wants to find out
Vitiligo is the most common depigmentation disorder affecting around 1% of the population worldwide. Fifty two percent of patients develop vitiligo before the age of 20 and around 80% develop vitiligo before the age of 30 years old.1 Vitiligo often presents in childhood and tends to be a lifelong disease, requiring prolonged courses of phototherapy.
Read full original descriptionShow less
Currently no national or international registry for patients with vitiligo exists. Individual dermatologists maintain a database of such patients, however no coordinated efforts have been made to combine these individual registries into a broader national registry. Finally, recently published British Association of Dermatologists (BAD) guideline for the management of vitiligo, recommended the development of a national registry for people with vitiligo undergoing systemic or light therapy to identify outcomes and safety.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Vitiligo Registry for Adults and Children in the UK (VIRTUAL-UK)
- Record updated
- 15 September 2026